Archives of Gynecology and Obstetrics

, Volume 284, Issue 2, pp 287–292 | Cite as

Heparanase expression in term placentas of diabetic patients and healthy controls

  • Doerte W. Luedders
  • Diana Bundschuh
  • Amadeus Hornemann
  • Jana-Christin Hoerster
  • Philipp Boemicke
  • Frank Köster
  • Michael K. BohlmannEmail author
Original Article



The prevalence of diabetic disorders in pregnancy is rising, which goes along with increased risks for maternal and foetal complications during pregnancy and delivery. The expression of the endo-β-d-glucuronidase, heparanase (HPSE), may increase under hyperglycaemic conditions, is believed to play an important role in diabetes associated morbidity outside the female reproductive tract and is expressed in the placenta throughout gestation. However, the placental expression of HPSE has not been investigated in diabetic patients.

Materials and methods

Placental biopsies of 30 patients with pre-existing or gestational diabetes and 30 healthy controls were analysed by real-time PCR and immunohistochemistry with regard to the presence of HPSE at term.


Patients and controls were comparable with respect to foetal outcome and maternal characteristics except for maternal body mass index. We were unable to show significant differences in placental HPSE expression between diabetic patients and healthy controls.


This study suggests that HPSE expression in term placentas is not affected by maternal diabetes and thus does not contribute to pathological processes in diabetic pregnancies with deliveries at term.


Placenta Heparanase Expression Diabetes Outcome RT-PCR Immunohistochemistry 



The authors wish to thank Drs. Thorben Ahrens, Kristin Baumann, Schima Djalali, David Hartge, Friederike Hoellen and Katharina Kelling for their help in the collection of placental tissue. We would furthermore like to thank Stephan Polack, who contributed substantially to the accurate performance of the experiments.

Conflict of interest



  1. 1.
    Horvath K, Koch K, Jeitler K, Matyas E, Bender R, Bastian H, Lange S, Siebenhofer A (2010) Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis. BMJ 340:c1395PubMedCrossRefGoogle Scholar
  2. 2.
    Ferrara A (2007) Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care 30(Suppl 2):141S–146SCrossRefGoogle Scholar
  3. 3.
    Bloomgarden ZT (2010) Gestational diabetes mellitus and obesity. Diabetes Care 33:e60–e65PubMedCrossRefGoogle Scholar
  4. 4.
    Vlodavsky I, Friedmann Y (2001) Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest 108:341–347PubMedGoogle Scholar
  5. 5.
    Nadir Y, Henig I, Naroditzky I, Paz B, Vlodavsky I, Brenner B (2010) Involvement of heparanase in early pregnancy losses. Thromb Res 125:e251–e257PubMedCrossRefGoogle Scholar
  6. 6.
    Klein U, Von Figura K (1976) Partial purification and characterization of heparan sulfate specific endoglucuronidase. Biochem Biophys Res Commun 73:569–576PubMedCrossRefGoogle Scholar
  7. 7.
    Haimov-Kochman R, Friedmann Y, Prus D, Goldman-Wohl DS, Greenfield C, Anteby EY, Aviv A, Vlodavsky I, Yagel S (2002) Localization of heparanase in normal and pathological human placenta. Mol Hum Reprod 8:566–573PubMedCrossRefGoogle Scholar
  8. 8.
    Miles JR, Vallet JL, Freking BA, Nonneman DJ (2009) Molecular cloning and characterisation of heparanase mRNA in the porcine placenta throughout gestation. Reprod Fertil Dev 21:757–772PubMedCrossRefGoogle Scholar
  9. 9.
    Kirn-Safran CB, D’Souza SS, Carson DD (2008) Heparan sulfate proteoglycans and their binding proteins in embryo implantation and placentation. Semin Cell Dev Biol 19:187–193PubMedCrossRefGoogle Scholar
  10. 10.
    Parish CR, Freeman C, Hulett MD (2001) Heparanase: a key enzyme involved in cell invasion. Biochim Biophys Acta 1471:M99–M108PubMedGoogle Scholar
  11. 11.
    Katz A, Van-Dijk DJ, Aingorn H, Erman A, Davies M, Darmon D, Hurvitz H, Vlodavsky I (2002) Involvement of human heparanase in the pathogenesis of diabetic nephropathy. Isr Med Assoc J 4:996–1002PubMedGoogle Scholar
  12. 12.
    Waterman M, Ben-Izhak O, Eliakim R, Groisman G, Vlodavsky I, Ilan N (2007) Heparanase upregulation by colonic epithelium in inflammatory bowel disease. Mod Pathol 20:8–14PubMedCrossRefGoogle Scholar
  13. 13.
    Vreys V, David G (2007) Mammalian heparanase: what is the message? J Cell Mol Med 11:427–452PubMedCrossRefGoogle Scholar
  14. 14.
    Maxhimer JB, Somenek M, Rao G, Pesce CE, Baldwin D Jr, Gattuso P, Schwartz MM, Lewis EJ, Prinz RA, Xu X (2005) Heparanase-1 gene expression and regulation by high glucose in renal epithelial cells: a potential role in the pathogenesis of proteinuria in diabetic patients. Diabetes 54:2172–2178PubMedCrossRefGoogle Scholar
  15. 15.
    Lewis EJ, Xu X (2008) Abnormal glomerular permeability characteristics in diabetic nephropathy: implications for the therapeutic use of low-molecular weight heparin. Diabetes Care 31(Suppl 2):S202–S207PubMedCrossRefGoogle Scholar
  16. 16.
    van den Hoven MJ, Rops AL, Vlodavsky I, Levidiotis V, Berden JH, van der Vlag J (2007) Heparanase in glomerular diseases. Kidney Int 72:543–548PubMedCrossRefGoogle Scholar
  17. 17.
    Grissa O, Yessoufou A, Mrisak I, Hichami A, Amoussou-Guenou D, Grissa A, Djrolo F, Moutairou K, Miled A, Khairi H, Zaouali M, Bougmiza I, Zbidi A, Tabka Z, Khan NA (2010) Growth factor concentrations and their placental mRNA expression are modulated in gestational diabetes mellitus: possible interactions with macrosomia. BMC Pregnancy Childbirth 10:7PubMedCrossRefGoogle Scholar
  18. 18.
    Holdsworth-Carson SJ, Lim R, Mitton A, Whitehead C, Rice GE, Permezel M, Lappas M (2010) Peroxisome proliferator-activated receptors are altered in pathologies of the human placenta: gestational diabetes mellitus, intrauterine growth restriction and preeclampsia. Placenta 31:222–229PubMedCrossRefGoogle Scholar
  19. 19.
    Colomiere M, Permezel M, Riley C, Desoye G, Lappas M (2009) Defective insulin signaling in placenta from pregnancies complicated by gestational diabetes mellitus. Eur J Endocrinol 160:567–578PubMedCrossRefGoogle Scholar
  20. 20.
    Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45PubMedCrossRefGoogle Scholar
  21. 21.
    Bohlmann MK, Luedders DW, Strowitzki T, von Wolff M (2010) Specific secretory phase endometrial leukocytes of women with two and more consecutive idiopathic abortions are not significantly different from healthy controls. Arch Gynecol Obstet 281:983–990PubMedCrossRefGoogle Scholar
  22. 22.
    Goshen R, Hochberg AA, Korner G, Levy E, Ishai-Michaeli R, Elkin M, de Groot N, Vlodavsky I (1996) Purification and characterization of placental heparanase and its expression by cultured cytotrophoblasts. Mol Hum Reprod 2:679–684PubMedCrossRefGoogle Scholar
  23. 23.
    Dempsey LA, Plummer TB, Coombes SL, Platt JL (2000) Heparanase expression in invasive trophoblasts and acute vascular damage. Glycobiology 10:467–475PubMedCrossRefGoogle Scholar
  24. 24.
    Harris LK, Baker PN, Brenchley PE, Aplin JD (2008) Trophoblast-derived heparanase is not required for invasion. Placenta 29:332–337PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Doerte W. Luedders
    • 1
  • Diana Bundschuh
    • 1
  • Amadeus Hornemann
    • 2
  • Jana-Christin Hoerster
    • 1
  • Philipp Boemicke
    • 1
  • Frank Köster
    • 1
  • Michael K. Bohlmann
    • 1
    Email author
  1. 1.Department of Obstetrics and GynecologyUniversity Hospital of Schleswig-HolsteinLübeckGermany
  2. 2.Department of Obstetrics and GynecologyUniversity Hospital Mannheim, University of HeidelbergMannheimGermany

Personalised recommendations